Treatment planning in implant dentistry - Colloquium
Treatment planning in implant dentistry - Colloquium
Treatment planning in implant dentistry - Colloquium
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
PROGRAMME<br />
& REGISTRATION<br />
www.eao.org<br />
Athens 2011PRELIMINARY<br />
October<br />
12-15, 2011<br />
Chairmen:<br />
Friedrich W. NEUKAM, Germany<br />
& Asterios DOUKOUDAKIS, Greece<br />
20 th Annual<br />
Scientific<br />
Meet<strong>in</strong>g<br />
<strong>Treatment</strong> Plann<strong>in</strong>g<br />
<strong>in</strong> Implant Dentistry<br />
In collaboration with the<br />
Greek Society of<br />
Prosthodontists<br />
Greek Society of<br />
Oral and Maxillofacial Radiology<br />
Greek Society<br />
for Osseo<strong>in</strong>tegration<br />
Greek Society of<br />
Periodontology
<strong>Treatment</strong> Plann<strong>in</strong>g<br />
<strong>in</strong> Implant Dentistry<br />
Dear colleagues,<br />
It is our great pleasure to announce that the 20 th Annual Meet<strong>in</strong>g of the EAO will take<br />
place <strong>in</strong> Athens from 13 th to 15 th October, 2011.<br />
‘Plann<strong>in</strong>g’ is an essential step prior to any treatment on patients. It deals with two core<br />
issues: what is the goal and how can we get there?<br />
Implant Dentistry is a grow<strong>in</strong>g and fast develop<strong>in</strong>g field. Hence, exactly def<strong>in</strong><strong>in</strong>g the goal<br />
<strong>in</strong> the range between the ‘patients’ wish’ and the ‘perfect state of the art’ has become a<br />
challenge itself. Plann<strong>in</strong>g the necessary steps towards the goal may allow to ship around<br />
the multiple trapdoors and pitfalls of Implant Dentistry. And last but not least <strong>plann<strong>in</strong>g</strong><br />
enables us to implement a quality management compar<strong>in</strong>g the cl<strong>in</strong>ical outcome to the<br />
projected goal.<br />
Avoid<strong>in</strong>g and manag<strong>in</strong>g complications, risk <strong>in</strong>dicators, load<strong>in</strong>g and treatment protocols<br />
and outcome predictability are just some important aspects of treatment <strong>plann<strong>in</strong>g</strong> which<br />
will be highlighted by the <strong>in</strong>vited speaker faculty, all of them highly respected scientists<br />
and cl<strong>in</strong>icians from all around the world. The choice between a broad variety of parallel<br />
sessions, master classes and oral presentations, accompanied by basic and cl<strong>in</strong>ical<br />
research as well as poster competitions and pre-congress step-by-step courses will<br />
satisfy the taste of everybody.<br />
The EAO ma<strong>in</strong> sponsors will provide further ‘<strong>in</strong>dustry satellite symposia’ and a large trade<br />
exhibition will be presented by the world’s lead<strong>in</strong>g companies.<br />
Athens is not only the capital but also the cultural and commercial center of Greece.<br />
Rooted <strong>in</strong> a history of more than 7 000 years, Athens provides overwhelm<strong>in</strong>g cultural<br />
treasures, where the Acropolis, a world cultural heritage of the UNESCO, is only the<br />
most famous one. Voted to be one of the European cultural capitals, the city provides a<br />
perfect comb<strong>in</strong>ation of modern life and ancient history which is accompanied by the cordial<br />
hospitality of the Greek – an excellent and <strong>in</strong>spir<strong>in</strong>g place to meet colleagues and friends.<br />
The 2011 EAO Scientific Committee set up a wonderful and <strong>in</strong>terest<strong>in</strong>g program.<br />
We want to thank all of them for their <strong>in</strong>valuable support and help.<br />
See you <strong>in</strong> Athens on the 2011 EAO Congress!<br />
Friedrich W. NEUKAM<br />
Asterios DOUKOUDAKIS<br />
Scientific Chairmen<br />
> Summary<br />
Synopsis & Committees . . . . . . . . . . . . . . . . 3<br />
EAO Association . . . . . . . . . . . . . . . . . . . 4<br />
Pre-Congress Courses . . . . . . . . . . . . . . . . 5<br />
Congress General Information . . . . . . . . . . . 15<br />
Registration . . . . . . . . . . . . . . . . . . . . . . 16<br />
Accommodation . . . . . . . . . . . . . . . . . . . 17<br />
2<br />
Scientific Sessions . . . . . . . . . . . . . . . . . . . 6<br />
Satellite Industry Symposia . . . . . . . . . . . . . 11<br />
Discover Athens . . . . . . . . . . . . . . . . . . 18
8h<br />
9h<br />
9h15<br />
10h<br />
11h<br />
12h<br />
13h<br />
14h<br />
15h<br />
16h<br />
16h15<br />
17h<br />
18h<br />
19h<br />
> <strong>Treatment</strong> Plann<strong>in</strong>g<br />
<strong>in</strong> Implant Dentistry<br />
Wed. Oct. 12 Thursday Oct. 13 Friday Oct. 14 Saturday Oct. 15<br />
3<br />
Pre-Congress<br />
Courses<br />
Welcome<br />
cocktail<br />
Exhibition Open<strong>in</strong>g<br />
Satellite Symposia<br />
Geistlich<br />
Osstell<br />
Straumann<br />
Welcome Address<br />
Plenary<br />
Session<br />
1<br />
Risk<br />
Indicators<br />
for Implant<br />
Therapy:<br />
Cl<strong>in</strong>ical<br />
Guidel<strong>in</strong>es<br />
Parallel<br />
Session<br />
1<br />
Load<strong>in</strong>g<br />
Protocols<br />
Satellite Symposia<br />
Astra Tech<br />
Scientific Committee<br />
Asterios DOUKOUDAKIS, Greece<br />
Klaus GOTFREDSEN, Denmark<br />
Nikos KATSIKERIS, Greece<br />
Antonis KONSTANTINIDIS, Greece<br />
Friedrich W. NEUKAM, Germany<br />
Franck RENOUARD, France<br />
Frank SCHWARZ, Germany<br />
Konstant<strong>in</strong>os TSIKLAKIS, Greece<br />
Biomet 3i<br />
Dentsply Friadent<br />
Breakfast Symposium<br />
Materialise<br />
Dental<br />
Plenary<br />
Session<br />
2<br />
Parallel<br />
Session<br />
2<br />
Keystone<br />
Dental<br />
Congress Ceremony<br />
Prevention<br />
of<br />
Problems<br />
Short Oral<br />
Communications<br />
EAO General Assembly<br />
Plenary Parallel<br />
Session Session<br />
3 3<br />
Predictability<br />
of<br />
Esthetic<br />
Outcomes<br />
Computer-<br />
Supported<br />
Fabrication<br />
of Implant<br />
Reconstructions<br />
<strong>Treatment</strong> Long-<br />
Plann<strong>in</strong>g Term<br />
with Predictability<br />
Experts<br />
Bti Biotechnology<br />
Institute<br />
Short Oral Communications<br />
Satellite Symposia<br />
Nobel Biocare<br />
Abstract Committee<br />
Co-Chairmen<br />
Ralf JOACHIM KOHAL, Germany<br />
Bjarni PJETURSSON, Iceland<br />
Søren SCHOU, Denmark<br />
Cl<strong>in</strong>ical Research Competition<br />
Zimmer Dental<br />
Members<br />
Matteo CHIAPASCO, Italy<br />
Nikolaos DONOS, United K<strong>in</strong>gdom<br />
Klaus GOTFREDSEN, Denmark<br />
Robert HAAS, Austria<br />
Flemm<strong>in</strong>g ISIDOR, Denmark<br />
Basic Research Competition<br />
Breakfast Symposium<br />
Southern Implant<br />
EAO Guidel<strong>in</strong>es for Diagnostic Imag<strong>in</strong>g <strong>in</strong><br />
Implant Dentistry 2011: Overview<br />
Parallel Plenary<br />
Session Session<br />
4 4<br />
Controversial<br />
Issues<br />
Short Oral Communications<br />
Awards Ceremony<br />
Plenary Session 5<br />
Ma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g Long-Term Implant Outcomes<br />
Clos<strong>in</strong>g Ceremony<br />
Greek<br />
Session<br />
Prosthetic<br />
<strong>Treatment</strong><br />
Plann<strong>in</strong>g<br />
<strong>in</strong><br />
Implant<br />
Dentistry:<br />
Cl<strong>in</strong>ical<br />
Guidel<strong>in</strong>es<br />
Andrea MOMBELLI, Switzerland<br />
Timo NÄRHI, F<strong>in</strong>land<br />
Gerry RAGHOEBAR, The Netherlands<br />
Irena SAILER, Switzerland<br />
Henn<strong>in</strong>g SCHLIEPHAKE, Germany<br />
Lars SCHROPP, Denmark<br />
Massimo SIMION, Italy<br />
Jörg-Rudolf STRUB, Germany<br />
Hendrik TERHEYDEN, Germany<br />
Ann WENNERBERG, Sweden<br />
Jörg WILTFANG, Germany<br />
Faculty<br />
Ingemar ABRAHAMSON, Spa<strong>in</strong><br />
Jürgen BECKER, Germany<br />
Michael BERGLER, USA<br />
Rafael BLANES, Spa<strong>in</strong><br />
Urs BRÄGGER, Switzerland<br />
Matteo CHIAPASCO, Italy<br />
Vasilios CHRONOPOULOS, Greece<br />
Lyndon COOPER, USA<br />
Luca CORDARO, Italy<br />
Paolo CORTELLINI, Italy<br />
Hugo DE BRUYN, Belgium<br />
Nikolaos DONOS, United K<strong>in</strong>gdom<br />
Asterios DOUKOUDAKIS, Greece<br />
Stephan EITNER, Germany<br />
Marco ESPOSITO, United K<strong>in</strong>gdom<br />
Jocelyne FEINE, Canada<br />
Ioannis FOURMOUSIS, Greece<br />
Jaime A. GIL, Spa<strong>in</strong><br />
Klaus GOTFREDSEN, Denmark<br />
Robert HAAS, Austria<br />
Christoph HÄMMERLE, Switzerland<br />
David HARRIS, Ireland<br />
Simone HEUBERER, Austria<br />
Stefan HOLST, Germany<br />
Ronald JUNG, Switzerland<br />
Rüdiger JUNKER, The Netherlands<br />
Demos KALYVAS, Greece<br />
Phophi KAMPOSIORA, Greece<br />
Joseph KAN, USA<br />
Theodoros KAPOS, USA<br />
Loannis KAROUSSIS, Greece<br />
Nikolaos KATSIKERIS, Greece<br />
Matthias KERN, Germany<br />
Björn KLINGE, Sweden<br />
Odd Carsten KOLDSLAND, Norway<br />
Antonis KONSTANTINIDIS, Greece<br />
Stefanos KOURTIS, Greece<br />
Thomas KVIST, Sweden<br />
Phoebus N. MADIANOS, Greece<br />
Carlos MADRID, Switzerland<br />
Georg MAILATH-POKORNY, Austria<br />
Carlo MAIORANA, Italy<br />
Athanasios MANGOS, Greece<br />
Henny J. MEIJER, The Netherlands<br />
Konrad MEYENBERG, Switzerland<br />
Andrea MOMBELLI, Switzerland<br />
Ailsa NICOL, United K<strong>in</strong>gdom<br />
David NISAND, France<br />
Emeka NKENKE, Germany<br />
Sandro PALLA, Switzerland<br />
Panos N. PAPAPANOU, USA<br />
George PAPAVASILEIOU, Greece<br />
Bjarni PJETURSSON, Iceland<br />
Frank RENOUARD, France<br />
Isabella ROCCHIETTA, Italy<br />
Ilia ROUSSOU, Greece<br />
Irena SAILER, Switzerland<br />
Giovanni SALVI, Switzerland<br />
Henn<strong>in</strong>g SCHLIEPHAKE, Germany<br />
David SCHNEIDER, Switzerland<br />
Søren SCHOU, Denmark<br />
Frank SCHWARZ, Germany<br />
Alberto SICILIA-FELECHOSA, Spa<strong>in</strong><br />
Massimo SIMION, Italy<br />
Sjoerd SMEEKENS, The Netherlands<br />
Paul STONE, United K<strong>in</strong>gdom<br />
Nikitas SYKARAS, Greece<br />
Gabor TEPPER, Austria<br />
Tiziano TESTORI, Italy<br />
Daniel THOMA, Switzerland<br />
Kostas TSIKLAKIS, Greece<br />
Pascal VALENTINI, France<br />
Nel VAN ASSCHE, Belgium<br />
Georg WATZEK, Austria<br />
3
EAO Board Members (2010-2011)<br />
> The EAO<br />
President<br />
Paul STONE, United K<strong>in</strong>gdom<br />
Past President<br />
Christoph HÄMMERLE, Switzerland<br />
President Elect.<br />
Søren SCHOU, Denmark<br />
Secretary General<br />
Pascal VALENTINI, France<br />
Treasurer<br />
Marc QUIRYNEN, Belgium<br />
Board Members<br />
Luca CORDARO, Italy<br />
Björn KLINGE, Sweden<br />
Henn<strong>in</strong>g SCHLIEPHAKE, Germany<br />
Alberto SICILIA FELECHOSA, Spa<strong>in</strong><br />
EAO Council (2010-2011)<br />
Chairman<br />
Massimo SIMION, Italy<br />
Members<br />
David HARRIS, Ireland<br />
Franck RENOUARD, France<br />
Georg WATZEK, Austria<br />
History<br />
The European Association of Osseo<strong>in</strong>tegration (EAO) is a nonprofit<br />
organisation founded <strong>in</strong> Munich <strong>in</strong> 1991 follow<strong>in</strong>g on the<br />
recommendations made by an <strong>in</strong>ternational group of cl<strong>in</strong>icians and<br />
research workers. It was formed as an <strong>in</strong>ternational, <strong>in</strong>terdiscipl<strong>in</strong>ary<br />
and <strong>in</strong>dependent science-based forum for all professionals <strong>in</strong>terested<br />
<strong>in</strong> the art and science of osseo<strong>in</strong>tegration.<br />
Vision<br />
Bridg<strong>in</strong>g the gap between science and cl<strong>in</strong>ical practice, EAO improves<br />
the quality of patient care as the lead<strong>in</strong>g voice and resource centre <strong>in</strong><br />
the field of <strong>implant</strong> <strong>dentistry</strong> <strong>in</strong> Europe<br />
Mission<br />
The objectives of the EAO are the follow<strong>in</strong>g:<br />
1. To promote and facilitate cl<strong>in</strong>ical applications of osseo<strong>in</strong>tegration<br />
for the benefit of patients throughout the world.<br />
2. To promote the advancement of methods of treatment <strong>in</strong><br />
reconstructive surgery and prosthetic rehabilitation based on the<br />
pr<strong>in</strong>ciples of osseo<strong>in</strong>tegration and related discipl<strong>in</strong>es.<br />
3. To promote and <strong>in</strong>itiate research <strong>in</strong>to improved cl<strong>in</strong>ical procedures<br />
for rehabilitation as a consequence of osseo<strong>in</strong>tegration.<br />
4. To promote <strong>in</strong>ternational exchange of knowledge and understand<strong>in</strong>g<br />
of the techniques and research <strong>in</strong> the field of osseo<strong>in</strong>tegration and<br />
related discipl<strong>in</strong>es.<br />
5. To promote the publication of research f<strong>in</strong>d<strong>in</strong>gs and other materials<br />
as part of cont<strong>in</strong>u<strong>in</strong>g education for the benefit of members and<br />
<strong>in</strong>terested organizations.<br />
Membership<br />
93 % of our members at the congress <strong>in</strong> Zurich (2006) said they<br />
would recommend EAO to a colleague. Jo<strong>in</strong> EAO now and benefit<br />
from a substantially reduced registration fee to the Annual Congress!<br />
In addition you will enjoy other membership benefits such as free<br />
onl<strong>in</strong>e subscription to the monthly Blackwell Cl<strong>in</strong>ical Oral Implants<br />
Research journal (12 issues per year), 74 % reduction to the hard<br />
copy subscription of COIR, 35 % reduction for onl<strong>in</strong>e & hard copy<br />
subscription to a selection of 5 other journals (Cl<strong>in</strong>ical Implant<br />
Dentistry and Related Research, Journal of Cl<strong>in</strong>ical Periodontology,<br />
Journal of Aesthetic and Restorative Dentistry, Journal of Oral<br />
Rehabilitation, and Oral Surgery), the EAO Newsletter twice a year,<br />
a membership directory conta<strong>in</strong><strong>in</strong>g the names and addresses of all<br />
members, a personal EAO p<strong>in</strong>, and a wide network of colleagues and<br />
lead<strong>in</strong>g <strong>in</strong>novators from around the world.<br />
For more <strong>in</strong>formation on membership, please contact:<br />
4<br />
EAO Office<br />
Ms Ir<strong>in</strong>a Mansurova<br />
EAO – 287 Avenue Louise, 4 th floor<br />
1050 Brussels – Belgium<br />
Tel +32 (0)2 643 20 49<br />
Fax +32 (0)2 645 26 71<br />
eao@congrex.com<br />
www.eao.org
WEDNESDAY<br />
THURSDAY<br />
FRIDAY<br />
SATURDAY<br />
> Pre-Congress Courses<br />
3 parallel and optional pre-congress courses are organized the day before the official open<strong>in</strong>g<br />
and will focus on specific topics. Please be advised that <strong>in</strong> order to guaranty <strong>in</strong>teractivity<br />
dur<strong>in</strong>g the courses, the numbers of seats are limited.<br />
Therefore, we recommend early registration for those who would be <strong>in</strong>terested <strong>in</strong> attend<strong>in</strong>g.<br />
To register for the course, participants must be registered to the Congress.<br />
Entrance fee is 150 € (VAT <strong>in</strong>cluded).<br />
On-l<strong>in</strong>e registration is available on the congress website: www.eao-congress.com<br />
Wednesday, 12 th October<br />
Afternoon<br />
PRE-CONGRESS<br />
COURSE 1<br />
AVOIDING AND MANAGING POOR IMPLANT POSITIONING<br />
Chairperson: Isabella ROCCHIETTA, Italy<br />
Speaker: David SCHNEIDER, Switzerland<br />
PRE-CONGRESS<br />
COURSE 2<br />
AVOIDING AND MANAGING SURGICAL AND BIOLOGICAL<br />
COMPLICATIONS<br />
Chairperson: Carlo MAIORANA, Italy<br />
Speaker: Giovanni SALVI, Switzerland<br />
PRE-CONGRESS<br />
COURSE 3<br />
AVOIDING AND MANAGING PROSTHODONTIC COMPLICATIONS<br />
Chairperson: Georg MAILATH-POKORNY, Austria<br />
Speaker: Stephan EITNER, Germany<br />
5
<strong>Treatment</strong> Plann<strong>in</strong>g <strong>in</strong> Implant Dentistry<br />
> Plenary Sessions<br />
Thursday, 13 th October<br />
Afternoon<br />
RISK INDICATORS FOR IMPLANT THERAPY: CLINICAL GUIDELINES<br />
Chairpersons: Asterios DOUKOUDAKIS, Greece and Paul STONE, United K<strong>in</strong>gdom<br />
PLENARY SESSION 1<br />
Genetic predictability for <strong>implant</strong> loss<br />
Nikolaos DONOS, United K<strong>in</strong>gdom<br />
Hardware characteristics affect<strong>in</strong>g<br />
peri-<strong>implant</strong> diseases<br />
Klaus GOTFREDSEN, Denmark<br />
Long-term <strong>implant</strong> prognosis <strong>in</strong><br />
periodontal patients<br />
Loannis KAROUSSIS, Greece<br />
Medically compromised patients<br />
Emeka NKENKE, Germany<br />
Is peri<strong>implant</strong>itis a risk for systemic<br />
diseases<br />
Panos N. PAPAPANOU, USA<br />
Discussion:<br />
Asterios DOUKOUDAKIS, Greece<br />
& Paul STONE, United K<strong>in</strong>gdom<br />
Friday, 14 th October<br />
Morn<strong>in</strong>g<br />
PLENARY SESSION 2<br />
COMPUTER-SUPPORTED FABRICATION OF IMPLANT<br />
RECONSTRUCTIONS<br />
Chairpersons: Christoph HÄMMERLE, Switzerland and Athanasios MANGOS, Greece<br />
Digital changes and their <strong>in</strong>fluence on<br />
the lab – European picture<br />
Michael BERGLER, USA<br />
Digital impression tak<strong>in</strong>g<br />
Theodorus KAPOS, USA<br />
Digital design and fabrication of<br />
reconstructions<br />
Matthias KERN, Germany<br />
Digital registration of functional<br />
patterns<br />
Sandro PALLA, Switzerland<br />
Discussion:<br />
Christoph HÄMMERLE, Switzerland<br />
& Athanasios MANGOS, Greece<br />
6
WEDNESDAY<br />
THURSDAY<br />
FRIDAY<br />
SATURDAY<br />
Friday, 14 th October<br />
Afternoon<br />
TREATMENT PLANNING WITH EXPERTS<br />
Chairpersons: Ronald JUNG, Switzerland and Massimo SIMION, Italy<br />
PLENARY SESSION 3<br />
Computer technology applications<br />
Lyndon COOPER, USA<br />
Microbiological test<strong>in</strong>g<br />
Andrea MOMBELLI, Switzerland<br />
Ideal fixed prosthodontic treatment<br />
from a biological po<strong>in</strong>t of view<br />
Sjoerd SMEEKENS, The Netherlands<br />
Indications for <strong>implant</strong> treatment<br />
from a patient’s po<strong>in</strong>t of view<br />
Gabor TEPPER, Austria<br />
Updated guidel<strong>in</strong>es on imag<strong>in</strong>g <strong>in</strong><br />
Implantology<br />
Kostas TSIKLAKIS, Greece<br />
Discussion:<br />
Ronald JUNG, Switzerland<br />
& Massimo SIMION, Italy<br />
Saturday, 15 th October<br />
Morn<strong>in</strong>g<br />
PLENARY SESSION 4<br />
PREDICTABILITY OF ESTHETIC OUTCOMES<br />
Chairpersons: Jaime A. GIL, Spa<strong>in</strong> and Franck SCHWARZ, Germany<br />
Predictable ma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g papilla<br />
techniques<br />
Paolo CORTELLINI, Italy<br />
Provisional prosthetic treatment:<br />
key factor of the aesthetic outcome<br />
Stefan HOLST, Germany<br />
Postextraction sites – impact of<br />
buccal bone on esthetics<br />
Joseph KAN, USA<br />
Does biology <strong>in</strong>fluence the aesthetic<br />
outcome?<br />
Henny J. MEIJER, The Netherlands<br />
Discussion:<br />
Jaime A. GIL, Spa<strong>in</strong><br />
& Franck SCHWARZ, Germany<br />
Saturday, 15 th October<br />
Afternoon<br />
PLENARY SESSION 5<br />
MAINTAINING LONG-TERM IMPLANT OUTCOMES<br />
Chairpersons: Bjarni PJETURSSON, Iceland and Irena SAILER, Switzerland<br />
Application of periodontal soft tissue<br />
surgery techniques to peri-<strong>implant</strong><br />
defects - peri-<strong>implant</strong> recession defect<br />
management<br />
Jürgen BECKER, Germany<br />
Management of peri<strong>implant</strong>itis<br />
Ioannis FOURMOUSIS, Greece<br />
Prevalence, extent and severity of<br />
perio-<strong>implant</strong>itis<br />
Odd Carsten KOLDSLAND, Norway<br />
Risk factors of peri<strong>implant</strong>itis<br />
Phoebus N. MADIANOS, Greece<br />
Discussion:<br />
Bjarni PJETURSSON, Iceland<br />
& Irena SAILER, Switzerland<br />
7
<strong>Treatment</strong> Plann<strong>in</strong>g <strong>in</strong> Implant Dentistry<br />
> Parallel Sessions<br />
Thursday, 13 th October<br />
Afternoon<br />
LOADING PROTOCOLS<br />
Chairpersons: Antonis KONSTANTINIDIS, Greece and Søren SCHOU, Denmark<br />
PARALLEL SESSION 1<br />
Influence of <strong>implant</strong> surface<br />
characteristics and <strong>implant</strong> length on<br />
the immediate load<strong>in</strong>g protocol<br />
Rüdiger JUNKER, The Netherlands<br />
Influence of the immediate load<strong>in</strong>g<br />
protocol on the outcome <strong>in</strong> the<br />
esthetic zone<br />
Konrad MEYENBERG, Switzerland<br />
Influence of hard and soft tissue<br />
augmentation procedures<br />
Isabella ROCCHIETTA, Italy<br />
Influence of the immediate load<strong>in</strong>g<br />
protocol <strong>in</strong> partially edentulous and<br />
edentulous patients<br />
Tiziano TESTORI, Italy<br />
Discussion:<br />
Antonis KONSTANTINIDIS, Greece & Søren SCHOU, Denmark<br />
Friday, 14 th October<br />
Morn<strong>in</strong>g<br />
PARALLEL SESSION 2<br />
PREVENTION OF PROBLEMS<br />
Chairpersons: Kostas TSIKLAKIS, Greece and Georg WATZEK, Austria<br />
Can we prevent biomechanical<br />
complications?<br />
Rafael BLANES, Spa<strong>in</strong><br />
Implant treatment of the grow<strong>in</strong>g –<br />
malpractice or challenge<br />
Simone HEUBERER, Austria<br />
Compromised patients – limitations<br />
and goals<br />
Carlos MADRID, Switzerland<br />
Comparison of two bone substitutes<br />
to treat dehiscencies along <strong>implant</strong>s<br />
Nele VAN ASSCHE, Belgium<br />
Discussion:<br />
Kostas TSIKLAKIS, Greece & Georg WATZEK, Austria<br />
Friday, 14 th October<br />
Afternoon<br />
PARALLEL SESSION 3<br />
LONG-TERM PREDICTABILITY<br />
Chairpersons: Nikolaos KATSIKERIS, Greece and Pascal VALENTINI, France<br />
Immediate <strong>implant</strong> placement versus<br />
delayed<br />
Hugo DE BRUYN, Belgium<br />
Long-term outcomes of vertical<br />
augmentation procedures<br />
Matteo CHIAPASCO, Italy<br />
Fixed versus removable rehabilitation<br />
Jocelyne FEINE, Canada<br />
S<strong>in</strong>us augmentations versus short<br />
<strong>implant</strong>s<br />
Daniel THOMA, Switzerland<br />
8 Discussion:<br />
Nikolaos KATSIKERIS, Greece & Pascal VALENTINI, France
WEDNESDAY<br />
THURSDAY<br />
FRIDAY<br />
SATURDAY<br />
Saturday, 15 th October<br />
Morn<strong>in</strong>g<br />
GREEK SESSION<br />
PROSTHETIC TREATMENT PLANNING IN IMPLANT DENTISTRY:<br />
CLINICAL GUIDELINES<br />
Chairpersons: Klaus GOTFREDSEN, Denmark and Pascal VALENTINI, France<br />
Pre-prosthetic surgical <strong>plann<strong>in</strong>g</strong><br />
Demos KALYVAS, Greece<br />
Predict<strong>in</strong>g and achiev<strong>in</strong>g the f<strong>in</strong>al<br />
result with <strong>implant</strong> restorations for<br />
edentulous patients<br />
Stefanos KOURTIS, Greece<br />
Stepped approach for restor<strong>in</strong>g<br />
functionally and esthetically the lost<br />
prosthetic space<br />
Vasilios CHRONOPOULOS, Greece<br />
Advanced problem solv<strong>in</strong>g: go<strong>in</strong>g back<br />
to the basics<br />
George PAPAVASILEIOU, Greece<br />
Solv<strong>in</strong>g the equation: esthetics vs.<br />
Function<br />
Phophi KAMPOSIORA, Greece<br />
Implant supported overdentures:<br />
comb<strong>in</strong><strong>in</strong>g function and esthetics<br />
Nikitas SYKARAS, Greece<br />
Bruxism and <strong>implant</strong> rehabilitation<br />
Ilia ROUSSOU, Greece<br />
Saturday, 15 th October<br />
Morn<strong>in</strong>g<br />
EAO<br />
STATEMENT<br />
EAO GUIDELINES FOR DIAGNOSTIC IMAGING IN IMPLANT<br />
DENTISTRY 2011: OVERVIEW<br />
Speaker: David HARRIS, Ireland<br />
Saturday, 15 th October<br />
Morn<strong>in</strong>g<br />
PARALLEL SESSION 4<br />
CONTROVERSIAL ISSUES<br />
Chairpersons: Björn KLINGE, Sweden and David NISAND, France<br />
The biological width – a myth revised<br />
Ingemar ABRAHAMSON, Spa<strong>in</strong><br />
Efficacy of short <strong>implant</strong>s versus longer<br />
<strong>implant</strong>s placed <strong>in</strong> augmented bone<br />
Marco ESPOSITO, United K<strong>in</strong>gdom<br />
Augmentation versus angulation<br />
Urs BRÄGGER, Switzerland<br />
Endodontic treatment versus <strong>implant</strong><br />
placement<br />
Thomas KVIST, Sweden<br />
Discussion:<br />
Björn KLINGE, Sweden & David NISAND, France<br />
9
<strong>Treatment</strong> Plann<strong>in</strong>g <strong>in</strong> Implant Dentistry<br />
WEDNESDAY<br />
THURSDAY<br />
FRIDAY<br />
SATURDAY<br />
Friday, 14 th October<br />
Morn<strong>in</strong>g<br />
> SHORT ORAL COMMUNICATIONS<br />
Chairpersons: Luca CORDARO, Italy and Ailsa NICOL, United K<strong>in</strong>gdom<br />
Friday, 14 th October<br />
Lunch time<br />
> EAO GENERAL ASSEMBLY<br />
Friday, 14 th October<br />
Afternoon<br />
> CLINICAL RESEARCH COMPETITION<br />
Chairpersons: David HARRIS, Ireland and Alberto SICILIA FELECHOSA, Spa<strong>in</strong><br />
> SHORT ORAL COMMUNICATIONS<br />
Chairperson: Robert HAAS, Austria<br />
Saturday, 15 th October<br />
Morn<strong>in</strong>g<br />
> SHORT ORAL COMMUNICATIONS<br />
Chairpersons: Theodoros KAPOS, USA and Franck RENOUARD, France<br />
> BASIC RESEARCH COMPETITION<br />
Chairpersons: Nikolaos DONOS, United K<strong>in</strong>gdom and Henn<strong>in</strong>g SCHLIEPHAKE, Germany<br />
Saturday, 15 th October<br />
Afternoon<br />
> AWARD CEREMONY<br />
10
WEDNESDAY<br />
THURSDAY<br />
FRIDAY<br />
SATURDAY<br />
> Satellite Industry Symposia<br />
Thursday, 13 th October<br />
Morn<strong>in</strong>g<br />
Thursday, 13 th October<br />
Morn<strong>in</strong>g<br />
Thursday, 13 th October<br />
Morn<strong>in</strong>g<br />
GEISTLICH<br />
OSSTELL<br />
STRAUMANN<br />
<strong>Treatment</strong> concepts for improved<br />
outcomes<br />
Prevention and treatments for optimal<br />
ma<strong>in</strong>tenance of hard and soft tissues<br />
Prof. Dr. Christoph HÄMMERLE,<br />
Switzerland<br />
Today, different cl<strong>in</strong>ical strategies are<br />
available regard<strong>in</strong>g ma<strong>in</strong>tenance of the<br />
<strong>in</strong>tact and reconstruction of the deficient<br />
ridge. Various techniques to deal with<br />
extraction sockets have recently been<br />
published show<strong>in</strong>g controversial data.<br />
Among the methods presently employed<br />
guided bone regeneration (GBR) is the<br />
best documented for the augmentation of<br />
the bony alveolar ridge. In recent years,<br />
possibilities for augment<strong>in</strong>g soft tissues<br />
have been further developed and ref<strong>in</strong>ed.<br />
Transplant<strong>in</strong>g autogenic tissue or apply<strong>in</strong>g<br />
novel collagen matrices for soft tissue<br />
augmentation have shown positive and<br />
reliable cl<strong>in</strong>ical outcomes.<br />
Management of complications <strong>in</strong> s<strong>in</strong>us<br />
elevation<br />
Prof. Dr. Carlo MAIORANA, Italy<br />
S<strong>in</strong>us elevation is currently a reliable<br />
procedure for bone augmentation <strong>in</strong><br />
the posterior maxilla. Nevertheless,<br />
complications can arise from an <strong>in</strong>correct<br />
surgical procedure or from anatomical<br />
anomalies. Most of the time, such<br />
complications can be avoided by carefully<br />
evaluat<strong>in</strong>g the preoperative CT scan,<br />
listen<strong>in</strong>g to the medical history of the patient,<br />
and perform<strong>in</strong>g the surgical procedure<br />
<strong>in</strong> the proper way. All the most common<br />
complications and their management will be<br />
highlighted together with key aspects from<br />
the most recent literature.<br />
For more <strong>in</strong>formation please visit<br />
www.geistlich-pharma.com/athens<br />
Implant stability diagnostics with ISQ –<br />
optimal load<strong>in</strong>g decisions<br />
Use this opportunity to learn more about<br />
the latest developments and practice <strong>in</strong><br />
objective stability diagnostics.<br />
Three of the most renowned cl<strong>in</strong>icians<br />
<strong>in</strong> the field will present research and<br />
rationale for us<strong>in</strong>g Osstell ISQ <strong>in</strong> compell<strong>in</strong>g<br />
presentations:<br />
Speakers:<br />
Prof. Peter Moy, USA<br />
Prof. Lars Sennerby, Sweden<br />
Dr. Paolo Trisi, Italy<br />
Moderator: Dr. Marco Degidi, Italy<br />
Us<strong>in</strong>g Osstell and ISQ is rapidly becom<strong>in</strong>g a<br />
new standard as this is the only method to<br />
objectively diagnose <strong>implant</strong>s and measure<br />
<strong>implant</strong> stability. With Osstell and ISQ you<br />
can easily test an <strong>implant</strong> without risk<strong>in</strong>g any<br />
damage to bone-<strong>implant</strong> connection.<br />
There can always be difficulties <strong>in</strong><br />
determ<strong>in</strong><strong>in</strong>g the osseo<strong>in</strong>tegration status<br />
when an <strong>implant</strong> is to be loaded with the<br />
f<strong>in</strong>al prosthesis. Nevertheless, it is vital<br />
to know whether the <strong>implant</strong> is stable.<br />
Compare your <strong>in</strong>itial ISQ values from the<br />
<strong>implant</strong> placement, and you can easily<br />
ascerta<strong>in</strong> whether stability has developed<br />
as you had expected.<br />
Research today demonstrates that <strong>implant</strong>s<br />
can be subject to immediate or early load<strong>in</strong>g<br />
– as long as there is sufficient stability (all<br />
other relevant parameters considered). You<br />
can read <strong>in</strong> recent publications how the<br />
<strong>in</strong>itial ISQ-value can help you decide whether<br />
to go ahead with early or immediate load<strong>in</strong>g.<br />
In some cases there may be biological<br />
conditions demand<strong>in</strong>g additional treatment<br />
such as s<strong>in</strong>us-lifts, bone grafts, membranes<br />
etc. With higher risk cases your prime<br />
target may not be load<strong>in</strong>g the <strong>implant</strong> as<br />
early as possible. It may be more important<br />
to ensure that the <strong>implant</strong>s are heal<strong>in</strong>g as<br />
expected. As long as there is access to<br />
the <strong>implant</strong>, the ISQ-read<strong>in</strong>g will tell you the<br />
stability development and help you <strong>in</strong> your<br />
cl<strong>in</strong>ical evaluation.<br />
Advanc<strong>in</strong>g Solutions Through Cont<strong>in</strong>uity<br />
and Innovation<br />
Moderator<br />
Prof. Dr. Nikos Donos, United K<strong>in</strong>gdom<br />
Synthetic Biomaterials for GBR Today and<br />
Tomorrow – Improv<strong>in</strong>g Convenience for<br />
your Daily Practice<br />
Dr. Christer Dahl<strong>in</strong>, Sweden<br />
Vital bone is the decisive matrix for<br />
successful patient treatment <strong>in</strong> order to<br />
achieve reliable <strong>implant</strong> osseo<strong>in</strong>tegration and<br />
improve the esthetic outcome. Straumann’s<br />
regenerative portfolio, <strong>in</strong>clud<strong>in</strong>g the newly<br />
developed PEG-Membrane MembraGel<br />
and the well documented graft material<br />
BoneCeramic, offers a synthetic alternative<br />
to improve convenience for your daily<br />
practice.<br />
Advanc<strong>in</strong>g Implant Dentistry with New and<br />
Old Technologies<br />
Dr. Mario Roccuzzo, Italy<br />
New technologies are developed <strong>in</strong> order<br />
to simplify procedures and enhance<br />
predictability; However, long-term data are<br />
needed to assess the predictability of an<br />
<strong>implant</strong>. Therefore, it is beneficial when new<br />
technologies are based on exist<strong>in</strong>g and welldocumented<br />
solutions.<br />
Benefits of Us<strong>in</strong>g Orig<strong>in</strong>al Prosthetic<br />
Components for Implant-Supported<br />
Reconstructions<br />
Prof. Dr. Urs Braegger, Switzerland<br />
Increased availability of 3 rd party prosthetic<br />
components raises concerns over the<br />
reliability and efficacy of <strong>implant</strong>-abutment<br />
connections. It is important to emphasize<br />
and demonstrate the advantages of us<strong>in</strong>g<br />
orig<strong>in</strong>al prosthetic components for <strong>implant</strong>supported<br />
restorations.<br />
Please check our website for the speakers’<br />
abstracts, CVs and program updates:<br />
www.straumann.com/eao2011<br />
Read more about <strong>implant</strong> stability<br />
diagnostics and ISQ on www.isqforum.com<br />
11
<strong>Treatment</strong> Plann<strong>in</strong>g <strong>in</strong> Implant Dentistry<br />
> Satellite Industry Symposia<br />
Thursday, 13 th October<br />
Afternoon<br />
Thursday, 13 th October<br />
Afternoon<br />
Thursday, 13 th October<br />
Afternoon<br />
ASTRATECH DENTAL<br />
BIOMET 3i<br />
DENTSPLY FRIADENT<br />
A Good Even<strong>in</strong>g with Astra Tech<br />
Implant <strong>dentistry</strong> is all about recreat<strong>in</strong>g<br />
what nature once created. Under the right<br />
conditions, nature itself does the major part<br />
of the job. Our responsibility is to provide<br />
the right conditions. The latest example of<br />
this is the OsseoSpeed TX Profile <strong>implant</strong>.<br />
Prof. Wilfred Wagner and Dr. Robert Nölken<br />
will present outstand<strong>in</strong>g cl<strong>in</strong>ical results by<br />
us<strong>in</strong>g this new <strong>implant</strong>, specially designed<br />
for sloped ridge situations – prov<strong>in</strong>g that<br />
adapt<strong>in</strong>g with nature is truly reward<strong>in</strong>g.<br />
Dr. Irena Sailer will present her way of<br />
provid<strong>in</strong>g the right conditions for each<br />
<strong>in</strong>dividual patient by us<strong>in</strong>g customized<br />
<strong>implant</strong> prosthetics. The cont<strong>in</strong>uous<br />
evolution of Astra Tech Implant System<br />
is proof of our commitment to development<br />
and <strong>in</strong>novations based on cl<strong>in</strong>ical evidence<br />
– before, dur<strong>in</strong>g and after treatment;<br />
Prof. Lyndon Cooper’s presentation will<br />
cover five years of cl<strong>in</strong>ical experience with<br />
OsseoSpeed. What if we can create<br />
the future by go<strong>in</strong>g back to the roots -<br />
Prof. Tomas Albrektsson takes us back<br />
50 years to the time when the journey of<br />
osseo<strong>in</strong>tegration began.<br />
Moderator:<br />
Prof. Lyndon Cooper, USA<br />
Speakers:<br />
Implant esthetics with customized solutions<br />
Dr. Irena Sailer, Switzerland<br />
Tissue ma<strong>in</strong>tenance <strong>in</strong> sloped ridges with<br />
new <strong>implant</strong> design<br />
Prof. Wilfried Wagner and Dr. Robert<br />
Nölken, Germany<br />
Five years cl<strong>in</strong>ical experience with<br />
OsseoSpeed TM<br />
Prof. Lyndon Cooper, USA<br />
50 years of osseo<strong>in</strong>tegration – back to the<br />
roots<br />
Prof. Tomas Albrektsson, Sweden<br />
For more <strong>in</strong>formation visit our website:<br />
www.astratechdental.com<br />
University Lead Expertise vs. Daily Cl<strong>in</strong>ical<br />
Decisions:<br />
How Do They Benefit From Each Other?<br />
Speakers:<br />
Dr. Tiziano Testori<br />
Dr. Christian Stappert<br />
Dr. Tommie Van de Velde<br />
Content:<br />
As it applies for all medical sciences,<br />
<strong>dentistry</strong>’s ultimate aim is the best possible<br />
result from the patient treatment. Based on<br />
the <strong>in</strong>tense research done by universities<br />
and the <strong>in</strong>dustry, numerous <strong>in</strong>novations<br />
have positively <strong>in</strong>fluenced outcomes,<br />
allow<strong>in</strong>g dentists to have access to an<br />
<strong>in</strong>creas<strong>in</strong>g number of new products. This<br />
has lead to an evolution of the treatment<br />
options offered to patients.<br />
But, what is the role of the university today<br />
and how can that <strong>in</strong>fluence your everyday<br />
practice? Today cl<strong>in</strong>ical research and<br />
universities play a very important role <strong>in</strong><br />
determ<strong>in</strong><strong>in</strong>g which technologies and new<br />
products represent a true advantage for<br />
the dentist and the patient. This role helps<br />
both the <strong>in</strong>dustry and the cl<strong>in</strong>ical community<br />
to differentiate between challenges and<br />
opportunities and sets the direction for<br />
future developments.<br />
This program will be driven by renowned<br />
faculty leaders with ample experience on<br />
how to apply new concepts and products to<br />
enhance treatment protocols and therefore<br />
answer a key question: How can cont<strong>in</strong>ued<br />
cooperation between universities and dental<br />
practitioners lead to the best possible<br />
patient benefits over time?<br />
<strong>Treatment</strong> <strong>plann<strong>in</strong>g</strong> and patient<br />
disposition – Right decisions for<br />
endur<strong>in</strong>g hard and soft tissue stability<br />
DENTSPLY Friadent welcomes you to an<br />
excit<strong>in</strong>g forum with three outstand<strong>in</strong>g<br />
and crossth<strong>in</strong>k<strong>in</strong>g cl<strong>in</strong>icians shar<strong>in</strong>g their<br />
broad based knowledge and experience<br />
of develop<strong>in</strong>g criteria and rationales for<br />
successful decision-mak<strong>in</strong>g <strong>in</strong> <strong>implant</strong><br />
therapy.<br />
There is no standardized format for cl<strong>in</strong>ical<br />
success, def<strong>in</strong><strong>in</strong>g the optimum therapy<br />
for each patient <strong>in</strong>volves assessment of<br />
<strong>in</strong>dividual risks and present<strong>in</strong>g options.<br />
Besides effective and versatile treatment<br />
solutions, the ability to develop smart<br />
perspectives and flexible decisions is key for<br />
stable and predictable treatment outcomes.<br />
We <strong>in</strong>vite as our guest to the lectures of :<br />
Prof. Dr. He<strong>in</strong>er WEBER, Germany:<br />
Strategies and criteria for <strong>implant</strong><br />
placement and augmentation<br />
Learn more about the reasons for<br />
augmentation and the implications for the<br />
surgical protocol.<br />
Prof. Dr. Marc QUIRYNEN, Belgium:<br />
The impact of marg<strong>in</strong>al and apical<br />
periodontitis on <strong>implant</strong> success<br />
Learn how to consider and treat periodontal<br />
disease <strong>in</strong> the context of <strong>implant</strong> therapy.<br />
Prof. Dr. Getulio NOGUEIRA, Canada:<br />
Detection of risk factors and management<br />
of peri<strong>implant</strong>itis<br />
Learn how to prevent, assess and cure<br />
adverse tissue reaction around <strong>implant</strong>s.<br />
Dist<strong>in</strong>guished cl<strong>in</strong>ical experts and scientists<br />
jo<strong>in</strong><strong>in</strong>g a discussion moderated by Dr.<br />
Nigel SAYNOR, UK will challenge the<br />
presentations.<br />
Jo<strong>in</strong> us for a delightful mix of lectures and<br />
discussion ref<strong>in</strong>ed with Greek spirit, spiced<br />
with a touch of astute British humor.<br />
For lecture abstracts, please visit :<br />
www.dentsply-friadent.com/eao2011<br />
12
WEDNESDAY<br />
THURSDAY<br />
FRIDAY<br />
SATURDAY<br />
Friday, 14 th October<br />
Afternoon<br />
Friday, 14 th October<br />
Afternoon<br />
Friday, 14 th October<br />
Afternoon<br />
BTI : Biotechnology <strong>in</strong>stitute<br />
NOBEL BIOCARE<br />
ZIMMER DENTAL<br />
A biological approach to <strong>implant</strong>ology:<br />
Atrophic maxilla treatment with<br />
m<strong>in</strong>imum <strong>in</strong>vasive cl<strong>in</strong>ical techniques<br />
us<strong>in</strong>g plasma rich <strong>in</strong> growth factors<br />
(P.R.G.F®-ENDORET®)<br />
Speakers:<br />
Dr. Eduardo Anitua, Spa<strong>in</strong><br />
Patient wellness has always been the goal<br />
of every doctor do<strong>in</strong>g <strong>implant</strong>s. Quicker soft<br />
tissue heal<strong>in</strong>g, lower pa<strong>in</strong> and <strong>in</strong>flammation<br />
levels, BIC <strong>in</strong>crease on <strong>implant</strong>s, shorter<br />
osseo<strong>in</strong>tegration times, etc. are the drivers<br />
and expectations. Dr. Eduardo Anitua has<br />
spent the last 25 years do<strong>in</strong>g <strong>implant</strong>ology,<br />
do<strong>in</strong>g research and giv<strong>in</strong>g lectures about<br />
how to develop the less <strong>in</strong>vasive surgical<br />
protocols focussed on patients. Dur<strong>in</strong>g his<br />
professional life he has been develop<strong>in</strong>g<br />
the use of growth factor as a key tool to<br />
establish safe, repeatable and predictable<br />
surgical protocols when fac<strong>in</strong>g the most<br />
delicate cl<strong>in</strong>ical <strong>in</strong>dications: narrow crest,<br />
lack of vertical bone, s<strong>in</strong>us lift techniques,<br />
etc.<br />
Dr. Eduardo Anitua dur<strong>in</strong>g his lecture will<br />
have a review of his surgical protocols<br />
and will show long term follow up results<br />
to confirm the predictability of those<br />
protocols and the low <strong>in</strong>vasive level of them.<br />
In summary he will describe his biologically<br />
guided <strong>implant</strong>ology.<br />
Dr. Gorka Orive, Spa<strong>in</strong><br />
Dr. Orive will have a review about the last 15<br />
years of research on plasma rich <strong>in</strong> growth<br />
factors (P.R.G.F®-ENDORET®). He will<br />
detail several aspects l<strong>in</strong>ked to this cutt<strong>in</strong>g<br />
edge technique: protocol to obta<strong>in</strong> the four<br />
different formulations, precl<strong>in</strong>ical data,<br />
cl<strong>in</strong>ical studies, cl<strong>in</strong>ical results and scientific<br />
publications. He will expla<strong>in</strong> on detail the<br />
biologic concepts support<strong>in</strong>g this technique<br />
and why patients own prote<strong>in</strong>s are meant to<br />
be the best available biomaterial.<br />
Dr. Konstant<strong>in</strong>os Mantalenakis, Greece<br />
Dr. Konstant<strong>in</strong>os Mantalenakis will show his<br />
personal experience when apply<strong>in</strong>g these<br />
low <strong>in</strong>vasive protocols described before.<br />
Preferred <strong>Treatment</strong> Concepts for<br />
Today’s Patient needs<br />
<strong>Treatment</strong> <strong>plann<strong>in</strong>g</strong> of any <strong>implant</strong> case requires<br />
proper diagnosis based on conventional and/or<br />
digital technologies. The cl<strong>in</strong>ician’s goal is to serve<br />
the patient by reduc<strong>in</strong>g the number of treatment<br />
steps and by select<strong>in</strong>g the least <strong>in</strong>vasive treatment<br />
options as supported by the most relevant science.<br />
Well-executed treatment <strong>plann<strong>in</strong>g</strong> will offer the<br />
patient an effective and reliable result, improv<strong>in</strong>g<br />
his/her quality of life.<br />
This <strong>in</strong>teractive treatment <strong>plann<strong>in</strong>g</strong> session will<br />
be conducted by seven experienced cl<strong>in</strong>icians,<br />
researchers, presenters ;<br />
Dr Aris Tripodakis, Dr Luc Vriel<strong>in</strong>k, Dr Eirik<br />
Salvesen, Dr Eric Van Dooren, Dr Mauro Fradeani<br />
and Dr Christian Coachman<br />
under the lead of the moderator Dr Bernard Touati<br />
Session topics to be adressed and discussed by<br />
the experts:<br />
<strong>Treatment</strong> <strong>plann<strong>in</strong>g</strong> that focuses on surgical<br />
considerations and procedures for advanced<br />
residual ridge reduction <strong>in</strong> edentulous patients.<br />
<strong>Treatment</strong> strategies and related protocols <strong>in</strong><br />
<strong>implant</strong> <strong>dentistry</strong> for edentulous patients have<br />
changed dramatically and are be<strong>in</strong>g cont<strong>in</strong>ually<br />
ref<strong>in</strong>ed and developed. The aim of this treatment<br />
<strong>plann<strong>in</strong>g</strong> session is to focus on the specific<br />
needs of the edentulous patient and the selected<br />
management rationale for each specific case.<br />
<strong>Treatment</strong> <strong>plann<strong>in</strong>g</strong> for anterior partial edentulism<br />
with special emphasis on peri-<strong>implant</strong> soft tissue<br />
management considerations as well as f<strong>in</strong>al<br />
restorative options to provide long-last<strong>in</strong>g esthetic<br />
results.<br />
The aim of this treatment <strong>plann<strong>in</strong>g</strong> session is<br />
to identify and optimally control those factors<br />
that contribute to overall soft tissue health and<br />
stability <strong>in</strong> dental <strong>implant</strong> treatment. These<br />
factors <strong>in</strong>clude <strong>implant</strong> design, abutment type and<br />
shape, restoration contour and a meticulously<br />
and scrupulously executed sequence of cl<strong>in</strong>ical<br />
procedures.<br />
A knowledge of, and appreciation for esthetic,<br />
biocompatible and functional parameters needs<br />
to be comb<strong>in</strong>ed with precision of fit objectives<br />
and CAD/CAM technology to ensure optimal and<br />
rout<strong>in</strong>e treatment outcomes. The aim of this part<br />
of the treatment <strong>plann<strong>in</strong>g</strong> session is to identify<br />
those factors that contribute to long-last<strong>in</strong>g and<br />
esthetic results.<br />
Diagnostic, treatment <strong>plann<strong>in</strong>g</strong> through digital<br />
<strong>dentistry</strong>:<br />
Could new developments and features <strong>in</strong> CAD/CAM<br />
<strong>dentistry</strong> improve communication with<strong>in</strong> the dental<br />
team and <strong>in</strong>fluence even more reliable treatment<br />
outcomes <strong>in</strong> restorative driven treatments?<br />
distributor.markets@nobelbiocare.com<br />
Osseo<strong>in</strong>corporation with Trabecular<br />
Metal Implants.<br />
The best th<strong>in</strong>g next to bone.<br />
Implant technology has significantly evolved<br />
dur<strong>in</strong>g the last year, address<strong>in</strong>g most of the<br />
challenges for a better osseo<strong>in</strong>tegration and<br />
<strong>in</strong>creas<strong>in</strong>g the predictability of the treatments.<br />
But still some limitations rema<strong>in</strong> and new<br />
challenges need a response, have we reached<br />
the limit of the current technologies? Which<br />
is the next step for the future? Conventional<br />
textured or coated <strong>implant</strong> surfaces achieve<br />
bone-to-<strong>implant</strong> contact, or ongrowth.<br />
What if <strong>in</strong> addition to osseo<strong>in</strong>tegration, we<br />
could achieve Osseo<strong>in</strong>corporation? Trabecular<br />
Metal Technology is an <strong>in</strong>novative material<br />
designed for both ongrowth and <strong>in</strong>growth, or<br />
osseo<strong>in</strong>corporation.<br />
Prof. Dr. Markus Hürzeler, Germany<br />
Implant developments over the last 20<br />
years – successes and shortfalls.<br />
Prof. Dr. Markus Hürzeler will review the<br />
major developments <strong>in</strong> the technology of<br />
dental <strong>implant</strong>s over the last 20 years. He<br />
will reflect on the most critical milestones<br />
and assess their effects on enhanced<br />
treatment options and patient outcome.<br />
Michael Coll<strong>in</strong>s, Vice President of Research,<br />
Development and Education, Zimmer Dental,<br />
USA<br />
Trabecular Metal Implant: Research and<br />
development<br />
Michael Coll<strong>in</strong>s will give an overview of the<br />
research and development concept beh<strong>in</strong>d<br />
the new Trabecular Metal Dental Implant.<br />
An overview will be given on material<br />
properties, design rationale and the status<br />
and future plans of mechanical, animal and<br />
human trial programmes will be presented.<br />
Dr. Markus Schlee, Germany<br />
Cl<strong>in</strong>ical Experience with Trabecular Metal<br />
Implants<br />
Dr. Markus Schlee was the first dentist<br />
us<strong>in</strong>g the Trabecular Metal Dental Implant<br />
cl<strong>in</strong>ically <strong>in</strong> Europe. He conducted two<br />
studies on Trabecular Metal <strong>implant</strong>s<br />
(early load<strong>in</strong>g study and a non<strong>in</strong>terventional<br />
study). Moreover current concepts of<br />
better soft and hard tissue <strong>in</strong>tegration of<br />
dental <strong>implant</strong>s will be discussed. Based<br />
on the material properties comb<strong>in</strong>ed with<br />
optimized cl<strong>in</strong>ical procedures he will give<br />
an overview of his cl<strong>in</strong>ical experience and<br />
further possibilities with Trabecular Metal<br />
<strong>implant</strong>s.<br />
13
<strong>Treatment</strong> Plann<strong>in</strong>g <strong>in</strong> Implant Dentistry<br />
WEDNESDAY<br />
THURSDAY<br />
FRIDAY<br />
SATURDAY<br />
> Satellite Industry<br />
Breakfast Symposia<br />
Friday, 14 th October<br />
Morn<strong>in</strong>g<br />
Friday, 14 th October<br />
Morn<strong>in</strong>g<br />
Saturday, 15 th October<br />
Morn<strong>in</strong>g<br />
MATERIALISE DENTAL<br />
KEYSTONE DENTAL<br />
SOUTHERN IMPLANT<br />
Stereolithographic surgical guides:<br />
Your way to esthetic perfection<br />
With the ever grow<strong>in</strong>g range of digital<br />
dental solutions, <strong>in</strong>tegrat<strong>in</strong>g esthetic<br />
<strong>plann<strong>in</strong>g</strong> and delivery of outstand<strong>in</strong>g results<br />
is possible today. Three dimensional<br />
<strong>plann<strong>in</strong>g</strong> and <strong>implant</strong> therapy exemplified by<br />
SimPlant® and SurgiGuide® offers cl<strong>in</strong>icians<br />
detailed tools for complex cl<strong>in</strong>ical <strong>implant</strong><br />
scenarios. This presentation will focus<br />
on comprehensive <strong>in</strong>tegration of esthetic<br />
smile design, <strong>implant</strong> placement and<br />
restoration <strong>in</strong>volv<strong>in</strong>g the anterior maxilla.<br />
Learn how to <strong>in</strong>tegrate three dimensional<br />
<strong>plann<strong>in</strong>g</strong> for <strong>implant</strong> placement and esthetic<br />
management together with SimPlant®.<br />
Speaker: Lyndon F. Cooper, D.D.S., Ph.D.<br />
Dr Cooper is the Stall<strong>in</strong>gs Dist<strong>in</strong>guished<br />
Professor at the University of North Carol<strong>in</strong>a.<br />
Together with the UNC Prosthodontics<br />
program, Dr. Cooper explores cutt<strong>in</strong>g edge<br />
technologies related to Prosthodontics<br />
and will present his experience with digital<br />
<strong>plann<strong>in</strong>g</strong>, guided surgery and immediate<br />
provisionalization.<br />
www.materialisedental.com<br />
Genesis, The New Biomimetic Implant<br />
System<br />
The Genesis Biomimetic Implant System TM<br />
represents a major advance <strong>in</strong> <strong>implant</strong><br />
<strong>dentistry</strong> through its biomimetic design<br />
– a design <strong>in</strong>spired by nature. The unique<br />
benefits of the Genesis System <strong>in</strong>clude the<br />
potential to achieve immediate function<br />
with a natural look<strong>in</strong>g smile, allow<strong>in</strong>g the<br />
patient to leave the dentist’s office with a<br />
replacement tooth on the day of surgery.<br />
First used over 30 years ago, dental<br />
<strong>implant</strong>s have primarily focused on restor<strong>in</strong>g<br />
the function of natural teeth. Today, the<br />
Genesis System goes beyond simply<br />
restor<strong>in</strong>g function. Through its patented<br />
BioSpark surface, a nano-surface that<br />
mimics the structure of bone, the Genesis<br />
System creates a heal<strong>in</strong>g environment to<br />
optimize bone <strong>in</strong>tegration. In addition, the<br />
conical seal m<strong>in</strong>imizes area for bacterial<br />
colonization, and the medialized abutment<br />
connection shifts bacteria away from bone.<br />
F<strong>in</strong>ally, the unique AnaTite process results<br />
<strong>in</strong> the first-ever marketed p<strong>in</strong>k <strong>implant</strong> collar<br />
and a complete l<strong>in</strong>e of p<strong>in</strong>k prosthetics. The<br />
aesthetic breakthrough of the AnaTite<br />
process allows the Genesis System to<br />
project a more natural hue through the<br />
patient’s gum tissue for a more natural<br />
look<strong>in</strong>g smile.<br />
Speaker: Dr Monish Bhola, USA<br />
For more <strong>in</strong>formation about Genesis, The<br />
Biomimetic Implant System TM , please visit<br />
www.keystonedental.com.<br />
The Brightest Ideas <strong>in</strong> Dental Implants.<br />
Southern Implants has been provid<strong>in</strong>g<br />
lead<strong>in</strong>g edge <strong>implant</strong> solutions to surgeons<br />
and restorative dentists s<strong>in</strong>ce 1987. The<br />
company has evolved to the forefront of<br />
Dental Implant Innovations and offers truly<br />
unique and award w<strong>in</strong>n<strong>in</strong>g products, backed<br />
by extensive scientific data.<br />
This is an opportunity to ga<strong>in</strong> valuable<br />
<strong>in</strong>sight from some of the world’s lead<strong>in</strong>g<br />
specialists, researchers and cl<strong>in</strong>icians on<br />
these <strong>in</strong>novative products.<br />
MAX - Implant for Molar Tooth<br />
Replacement:<br />
The award w<strong>in</strong>n<strong>in</strong>g MAX <strong>implant</strong>, which<br />
permits immediate placement <strong>in</strong> molar<br />
sockets will be discussed.<br />
Focus will be on cl<strong>in</strong>ical research results<br />
and site preparation options.<br />
Co-Axis - Implants that Reduces the Need<br />
for Bone Grafts:<br />
The Co-axis <strong>implant</strong> optimises use of<br />
available bone without compromis<strong>in</strong>g<br />
restorative protocols.<br />
These <strong>implant</strong>s significantly reduce the<br />
complexity of immediate load<strong>in</strong>g.<br />
Moderator: Dr Stefan Vanderweghe<br />
Speakers:<br />
Dr Andrew Ackermann<br />
Dr Costa Nicolopoulos<br />
Prof Dale Howes<br />
14
Congress General Information<br />
Date<br />
From Wednesday 12 th , October to Saturday 15 th , October 2011<br />
Venue<br />
The EAO congress 2011 will be held at Megaron Athens International<br />
Conference Center (M.A.I.C.C.)<br />
Official language<br />
The official language of the EAO Congress is English. There will be<br />
simultaneous translation <strong>in</strong>to English and Greek dur<strong>in</strong>g plenary session.<br />
Visas<br />
All non-EU citizens should check with the Greece Embassy <strong>in</strong> their home<br />
country whether it is necessary for them to obta<strong>in</strong> a visa for travel to<br />
Greece.The adm<strong>in</strong>istrative secretariat “<strong>Colloquium</strong>” can provide upon<br />
request a certification letter to present to your local Embassy.<br />
Trade Exhibition<br />
A trade exhibition will be held <strong>in</strong> the MAICC while the congress takes<br />
place. It will offer an excellent opportunity for companies to display<br />
their products. Firms wish<strong>in</strong>g to exhibit may obta<strong>in</strong> <strong>in</strong>formation at<br />
eao2011@clq-group.com<br />
Important dates<br />
Deadl<strong>in</strong>e for registration at preferential rates: June 2 nd , 2011<br />
On-l<strong>in</strong>e registration is available on the congress official website,<br />
www.eao-congress.com<br />
Useful l<strong>in</strong>ks<br />
Venue: www.megaron.gr<br />
Tourism: www.greece-athens.com, www.athensguide.org<br />
Airport Athens: www.aia.gr<br />
Athens urban public transport: www.oasa.gr<br />
Car rentals, at the Airport: www.budget-athens.gr, www.europcar.com<br />
Restaurants: www.athensguide.com/restaurants.html<br />
Access<br />
Location and how to get to the MAICC Athens from the airport<br />
MAICC Athens address:<br />
Vas. Sofias Ave. & Kokkali St. - 115 21 Athens<br />
Ph. (+ 30) 210 728 2000<br />
MAICC is a 30 - 45 m<strong>in</strong>utes drive from Athens <strong>in</strong>ternational airport<br />
and 3 - 5 m<strong>in</strong>utes away from the city center.<br />
From any part of Athens, there are a number of options; car, bus,<br />
metro or taxi, that will br<strong>in</strong>g you to the front door of the MAICC Athens.<br />
Contact<br />
EAO 2011 c/o <strong>Colloquium</strong><br />
12 rue de la Croix-Faub<strong>in</strong> - 75011 Paris, France<br />
Ph. +33 (0)1 44 64 15 15 - Fax. +33 (0)1 44 64 15 16<br />
Email: eao2011@clq-group.com<br />
EAO Office c/o Congrex<br />
287 Avenue Louise, 4 th Floor - 1050 Brussels, Belgium<br />
Ph. +32 (0)2 643 20 49 - Fax. +32 (0)2 645 26 71<br />
Email: eao@congrex.com<br />
Web: www.eao.org<br />
Official Carrier<br />
Air France and KLM Global<br />
Meet<strong>in</strong>gs<br />
Event EAO 2011<br />
Event ID: 11947AF<br />
Valid for travel from October,<br />
7 th 2011 to October, 20 th 2011<br />
Event location: Athens - Greece<br />
Discounts are applied to a wide range<br />
of airfares on all AIR FRANCE and<br />
KLM flights worldwide.<br />
10 % rebate is applied on a range of<br />
published unrestricted public fares<br />
and 5 % on a large range of restricted<br />
fares.<br />
Use the website of this event or visit<br />
www.airfranceklm-globalmeet<strong>in</strong>gs.com<br />
to access:<br />
• the preferential fares granted for<br />
this event,<br />
• make your book<strong>in</strong>g,<br />
• issue your electronic ticket * ,<br />
• select your seat **<br />
• and pr<strong>in</strong>t your board<strong>in</strong>g card ** ,<br />
If you buy your ticket via AIR FRANCE<br />
& KLM Global Meet<strong>in</strong>gs website, your<br />
electronic ticket will carry a special<br />
mention which justifies the application<br />
of the preferential fares.<br />
Should you prefer to process your<br />
reservations and ticket-purchase<br />
directly with an AIR FRANCE and<br />
KLM sales outlet, you must keep<br />
this current document which serves<br />
to justify the application of the<br />
preferential airfares<br />
Keep the document to justify the<br />
special fares with you as you may<br />
be asked for it at any po<strong>in</strong>t of your<br />
journey.<br />
To locate your nearest AIR FRANCE<br />
and KLM sales po<strong>in</strong>t, visit www.<br />
airfrance.com or www.klm.com<br />
You will need to quote the reference<br />
given above which is registered <strong>in</strong><br />
AIR FRANCE & KLM data <strong>in</strong>to GDS<br />
Amadeus: GGAIRAFEVENTNEGO or<br />
GGAIRAFGLOBALMEETINGS<br />
Frequent flyer / loyalty programs of<br />
AIR FRANCE and KLM partner airl<strong>in</strong>es<br />
are credited with “miles” when Air<br />
France or KLM flights are used.<br />
*<br />
not available <strong>in</strong> certa<strong>in</strong> countries<br />
**<br />
subject to conditions<br />
15
<strong>Treatment</strong> Plann<strong>in</strong>g <strong>in</strong> Implant Dentistry<br />
> Registration<br />
16<br />
On-l<strong>in</strong>e registration is available on the website: www.eao.org<br />
Registration fees for delegates <strong>in</strong>clude<br />
> Admission to all congress sessions, poster areas and technical exhibition<br />
> The open<strong>in</strong>g ceremony<br />
> Congress documents (f<strong>in</strong>al programme, abstracts books, congress bag)<br />
> Lunches and coffee breaks<br />
Terms of payment<br />
> By credit card: Visa, Euro Cards or Master Cards<br />
Registration fees<br />
Jo<strong>in</strong> EAO now and secure a substantially reduced registration fee for the<br />
congress!<br />
On-l<strong>in</strong>e registration is available on the congress website: www.eao.org<br />
EAO<br />
members*<br />
and Greek<br />
National<br />
Association<br />
Members**<br />
Before<br />
June 2 nd ,<br />
2011<br />
Between<br />
June 2 nd and<br />
August 17 th ,<br />
2011<br />
After August<br />
17 th , 2011<br />
and on-site<br />
Pre-Congress<br />
courses ***<br />
450 € 540 € 590 € 150 €<br />
Non Member 590 € 690 € 760 € 150 €<br />
Undergraduate<br />
Student<br />
240 € 300 € 330 € 150 €<br />
All the above prices <strong>in</strong>clude Greek VAT of 23 %<br />
* Rate applicable for members hav<strong>in</strong>g paid their 2011 membership fee. The organization reserves the right to<br />
apply the non member fee otherwise.<br />
** Rate applicable for members of the follow<strong>in</strong>g Greek associations: Greek Society of Prosthodontists, Greek<br />
Society of Oral and Maxillofacial Radiology, Greek Society for Osseo<strong>in</strong>tegration, Greek Society of Periodontology<br />
*** To register for the course, participants must be registered to the Congress. Limited number of seats<br />
Important dates<br />
> Deadl<strong>in</strong>e for preferential registrations: June 2 nd , 2011<br />
> Late registrations will close on October 3 rd , 2011 at 18.00 (GMT + 1:00)<br />
> On site registrations will be available on October 12 th , 2011<br />
Cancellation Conditions<br />
All cancellations must be notified <strong>in</strong> writ<strong>in</strong>g (by mail or fax) to the Congress<br />
Office accord<strong>in</strong>g to the follow<strong>in</strong>g conditions:<br />
> Before July, 11 th : Reimbursement of 50 % of the fees paid. With no payment<br />
received before cancellation, this amount will still rema<strong>in</strong> due.<br />
> After July, 11 th : No refund. With no payment received before that date, the<br />
total amount will still rema<strong>in</strong> due to the Congress office.<br />
> All refunds will be issued after the congress. Requests will not be accepted<br />
after the 15 th of November 2011.<br />
A special rate is available for group registrations accord<strong>in</strong>g to the follow<strong>in</strong>g<br />
conditions:<br />
> M<strong>in</strong>imum of 5 participants<br />
> Deadl<strong>in</strong>e for submitt<strong>in</strong>g a purchase order: August 26 th , 2011<br />
> Invoice settlement upon receipt<br />
> Deadl<strong>in</strong>e for payment: September 16 th , 2011<br />
> Unique rate for all registration types (590 € VAT <strong>in</strong>cluded): no reduced fees<br />
will be applied<br />
> Your registration <strong>in</strong>terface will be available until September 30 th , 2011<br />
VAT<br />
<strong>in</strong>formation<br />
The Value Added Tax<br />
is <strong>in</strong>cluded <strong>in</strong> all fees of the<br />
congress. Accord<strong>in</strong>g to the local<br />
Tax legislation the registration<br />
fees, the satellite symposiums,<br />
exhibition and “packages” will be<br />
<strong>in</strong>voiced with Greek VAT 23 %.<br />
Only the sponsor<strong>in</strong>g sold without<br />
any other service will be <strong>in</strong>voiced<br />
accord<strong>in</strong>g the general rule<br />
of article 44 of the Directive<br />
112/2006/EC: Belgium VAT<br />
of 21 % for the companies<br />
established <strong>in</strong> Belgium, reverse<br />
charge for the companies<br />
established <strong>in</strong> EU country and<br />
without VAT for the companies<br />
established <strong>in</strong> non EU countries.<br />
Please note however that<br />
s<strong>in</strong>ce January 1 st 2010, EU<br />
companies that want to claim<br />
VAT back <strong>in</strong> another EU country<br />
have to submit their claims<br />
electronically through the<br />
electronic portal of the country<br />
where they are established.<br />
Claims are no longer sent<br />
directly by the applicant to the<br />
authorities of the Member State<br />
of refund.<br />
For non EU companies, Greece<br />
applies the pr<strong>in</strong>ciple of reciprocity<br />
and only Swiss companies are<br />
entitled to claim VAT back <strong>in</strong><br />
Greece. For Swiss companies,<br />
claims have to be submitted to<br />
the address <strong>in</strong>dicated above no<br />
later than June 30 th of the year<br />
follow<strong>in</strong>g the date of the <strong>in</strong>voice.<br />
The Greek tax authorities <strong>in</strong><br />
charge of process<strong>in</strong>g VAT refund<br />
claims are the follow<strong>in</strong>g:<br />
M<strong>in</strong>istry of F<strong>in</strong>ance<br />
14 th Directorate of VAT and<br />
Indirect Taxes<br />
S<strong>in</strong>a 2-4<br />
GR 10672 ATHENS
Accommodation<br />
Hotels <strong>in</strong> and around Athens<br />
Hotel rooms at special Congress rates are be<strong>in</strong>g held for congress participants <strong>in</strong> various hotels of different categories<br />
nearby the Megaron Conference Center and downtown.<br />
Indicated rates are per room, per night, <strong>in</strong>clusive of breakfast and local tax.<br />
Reservations must be made through the Congress Office to guarantee the <strong>in</strong>dicated rates negotiated for the Congress.<br />
Larissa<br />
Station<br />
Peloponnese<br />
Station<br />
A<br />
B<br />
Tsaldari<br />
I<br />
G<br />
Marni<br />
D<br />
J<br />
H<br />
F<br />
C G D<br />
E B<br />
H E<br />
C<br />
Agora<br />
F National<br />
Park<br />
Acropolis<br />
A<br />
28 Oktovriou Patission<br />
Eleftheriou Venizelou<br />
Stadiou<br />
Areos Park<br />
Amalias<br />
Strefi<br />
Vasilissis Sofias<br />
Vassileos Konstand<strong>in</strong>ou<br />
Alexandras<br />
Alsos<br />
Lykavittou<br />
Olympic Stadium - 1896<br />
Megaron<br />
Congress<br />
Center<br />
A<br />
City center<br />
B<br />
Most hotels are 5 to 20 m<strong>in</strong>utes walk<strong>in</strong>g distance or 2<br />
to 10 m<strong>in</strong>utes by taxi or metro from the MAICC.<br />
Hotel rooms have to be reserved on l<strong>in</strong>e to WIP on<br />
15 th , August 2011 at the latest.<br />
After this date, rooms cannot be guaranteed. Rooms<br />
will be provided on a first come first served basis. WIP<br />
will issue a letter confirm<strong>in</strong>g your reservation details.<br />
The cancellation policy is applicable to the Individual<br />
Hotel reservations.<br />
All cancellations must be made <strong>in</strong> writ<strong>in</strong>g (E-mail, letter<br />
or fax) to the Adm<strong>in</strong>istrative Secretariat accord<strong>in</strong>g to<br />
the follow<strong>in</strong>g conditions:<br />
> Before May 20 th : total amount will be refunded<br />
except 50 € for adm<strong>in</strong>istrative fees. With no<br />
payment received before cancellation, these 50 €<br />
will still rema<strong>in</strong> due.<br />
> After June 20 th : No refund. With no payment<br />
received before that date, the total amount will still<br />
rema<strong>in</strong> due to the Congress office.<br />
5 Star Hotels Distance from MAICC S<strong>in</strong>gle Rate Double Rate Superior S<strong>in</strong>gle Rate Superior Double Rate<br />
A) Athens Imperial 5 m<strong>in</strong>. by metro 160 € 170 € / /<br />
B) Crowne Plaza 3 m<strong>in</strong>.’ walk 280 € 290 € 220 € 230 €<br />
C) Divani Caravel 5 m<strong>in</strong>.’ walk 215 € 235 € 265 € 285 €<br />
D) Grande Bretagne 5 m<strong>in</strong>. by metro 225 € 246 € 286 € 307 €<br />
E) Hilton Athens 7 m<strong>in</strong>.’ walk 239 € 259 € 324 € 344 €<br />
F) Holiday Suites 7 m<strong>in</strong>.’ walk 210 € 220 € / /<br />
G) K<strong>in</strong>g Georges 2 m<strong>in</strong>.’ drive 250 € 270 € / /<br />
H) N.J.V Plaza 5 m<strong>in</strong>. by metro 210 € 220 € / /<br />
4 Star Hotels Distance from MAICC S<strong>in</strong>gle Rate Double Rate<br />
A) Airotel Alexandros 3 m<strong>in</strong>.’ walk 160 € 160 €<br />
B) Airotel Vassilikos 5 m<strong>in</strong>.’ walk 160 € 160 €<br />
For Group<br />
C) Athens Electra 5 m<strong>in</strong>. by metro 170 € 185 €<br />
D) Baby Grand 15 m<strong>in</strong>.’ drive 160 € 170 €<br />
E) Bw Ilisia 5 m<strong>in</strong>.’ walk 117 € 122 €<br />
F) Electra Palace 10 m<strong>in</strong>. by metro 215 € 225 €<br />
G) Fresh Hotel 10 m<strong>in</strong>. by metro 150 € 150 €<br />
H) Golden Age 2 m<strong>in</strong>.’ walk 140 € 140 €<br />
I) President 15 m<strong>in</strong>. by metro 150 € 150 €<br />
J) Titania 5 m<strong>in</strong>. by metro 150 € 150 €<br />
Group Book<strong>in</strong>g<br />
For group block book<strong>in</strong>gs<br />
(more than 4 rooms),<br />
please contact:<br />
eao2011@wipresa.com<br />
3 Star Hotels Distance from MAICC S<strong>in</strong>gle Rate Double Rate<br />
A) Acropolis Museum 15 m<strong>in</strong>. by metro 135 € 135 €<br />
B) Apollo 15 m<strong>in</strong>. by metro 50 € 68 €<br />
17
Discover Athens<br />
18<br />
> Athens<br />
As an <strong>in</strong>spir<strong>in</strong>g city,<br />
Athens is the perfect<br />
place to meet colleagues<br />
and friends while<br />
participat<strong>in</strong>g <strong>in</strong> one of the<br />
world’s lead<strong>in</strong>g conferences<br />
for <strong>implant</strong> <strong>dentistry</strong>.<br />
12<br />
Piraeus Port<br />
Italia<br />
Athens is the capital and<br />
largest city of Greece, and<br />
its economic, f<strong>in</strong>ancial,<br />
<strong>in</strong>dustrial, political and cultural centre.<br />
Surrounded by a l<strong>in</strong>e of stunn<strong>in</strong>g seas and<br />
mounta<strong>in</strong>s, this safe and travel-friendly city is<br />
one of the oldest ones <strong>in</strong> the world, as its<br />
recorded history spans back over 3,400<br />
years.<br />
WESTERN<br />
Ionian<br />
Sea<br />
11<br />
Greece<br />
Olympic Weightlift<strong>in</strong>g Hall - Nikaia<br />
Laimos Bay - Vouliagmeni<br />
Bulgaria<br />
Macedonia<br />
Albania<br />
Aegean<br />
Sea<br />
Athens<br />
Sea of Crete<br />
Crete<br />
Vouliagmeni Temple<br />
of Apollo Zoster<br />
Turkey<br />
13<br />
SOUTHERN<br />
9<br />
2<br />
Roman Agora<br />
Temple of Olympian Zeus<br />
Acropolis Theater<br />
Lake - Vougliameni<br />
1<br />
14
NORTHERN<br />
8<br />
National Archeological Museum<br />
3<br />
10<br />
4<br />
Olympic Complex<br />
Classical Athens was a powerful city-state, home of<br />
Plato's Academy, Aristotle's Lyceum and the<br />
birthplace of democracy and philosophy. It is widely<br />
referred to as the cradle of Western civilization and<br />
the heritage of the classical era is still evident today <strong>in</strong><br />
the city.<br />
Athens and its periphery Attica provide overwhelm<strong>in</strong>g<br />
treasures and famous attractions: well-renowned<br />
archaeological sites like the Parthenon, plus Roman,<br />
Byzant<strong>in</strong>e and some rema<strong>in</strong><strong>in</strong>g Ottoman monuments.<br />
The city is home to two UNESCO World Heritage<br />
Sites: the Acropolis of Athens and the medieval<br />
Daphni Monastery.<br />
A cosmopolitan metropolis, modern Athens is a<br />
major, vibrant European city and an important centre<br />
of culture, a place where history meets with comfort<br />
and fasc<strong>in</strong>ation. It offers modern and classical art<br />
museums and galleries, stylish shops, f<strong>in</strong>e restaurants<br />
and bars, street markets and bazaars, open-air<br />
c<strong>in</strong>emas, sandy beaches and 300 sun-drenched days.<br />
Hadrian’s Arch<br />
Greek Parliament<br />
Athens<br />
Historical Center<br />
Megaron<br />
Congress<br />
Center<br />
16<br />
Monastery - Kessariani<br />
5<br />
EASTERN<br />
Olympic Stadium - 1896<br />
7<br />
Parthenon<br />
> Facts and Figures<br />
Population (urban area of Athens):<br />
3 to 4 million <strong>in</strong>habitants (2001)<br />
4 th most populated capital of the EU.<br />
6<br />
National<br />
Garden<br />
Innovation and improvements <strong>in</strong> <strong>in</strong>frastructure alongside the new, award-w<strong>in</strong>n<strong>in</strong>g<br />
Athens International Airport – currently serv<strong>in</strong>g 80 <strong>in</strong>ternational dest<strong>in</strong>ations – have made Athens<br />
a city that is easy to navigate, <strong>in</strong>troduc<strong>in</strong>g a new era for its citizens and visitors alike.<br />
15<br />
National and Kapodistrian University of Athens<br />
Famous Athenians<br />
> Solon (poet and lawmaker)<br />
> Socrates (philosopher)<br />
19<br />
> Plato (philosopher)<br />
> Pericles (orator and statesman)<br />
> Constant<strong>in</strong> Papachristopoulos, aka Costi (sculptor)
EAO wishes to extend its special thanks<br />
to the follow<strong>in</strong>g Sponsors for their partnership<br />
Found<strong>in</strong>g Gold Sponsors<br />
Gold Sponsors<br />
Silver Sponsors<br />
Consult-PRO <br />
EAO Vision:<br />
Bridg<strong>in</strong>g the gap between<br />
science and cl<strong>in</strong>ical practice,<br />
EAO improves the quality of<br />
patient care as the lead<strong>in</strong>g voice<br />
and resource centre <strong>in</strong> the field of <strong>implant</strong> <strong>dentistry</strong> <strong>in</strong> Europe.<br />
Membership of the EAO br<strong>in</strong>gs a number of valuable benefits,<br />
<strong>in</strong>clud<strong>in</strong>g:<br />
• a substantially reduced rate for the Annual Scientific Congress<br />
• free subscription to the onl<strong>in</strong>e edition of Cl<strong>in</strong>ical Oral Implants<br />
Research<br />
(Wiley-Blackwell Publish<strong>in</strong>g, 12 editions per year)<br />
• 74 % reduction on hard copy subscriptions to Cl<strong>in</strong>ical Oral<br />
Implants Research (210 € <strong>in</strong>stead of 806 €)<br />
• EAO newsletter twice a year<br />
• access to a members only area of the website where you can<br />
view digital copies of the COIR and update your contact details<br />
• onl<strong>in</strong>e directory with names and address of all members<br />
• 35 % reduction on a selection of dental journals<br />
Please visit www.eao.org for further details<br />
EAO Press Office<br />
c/o PORTER NOVELLI<br />
272 Boulevard Louis Mettewie b5<br />
1080 Brussels, Belgium<br />
Ph. +32 (0)2 413 03 40<br />
Fax. +32 (0) 2 413 03 49<br />
Email: tim.edgar@porternovelli.be<br />
Web: www.eao.org<br />
© colloquium 05/11